Dr. Kwang Woo Ahn Appointed CIBMTR Chief Statistical Director
We are pleased to announce that Dr. Kwang Woo Ahn has been appointed Chief Statistical Director of the CIBMTR, effective September 1, 2024. Dr. Ahn is Professor in the Division of Biostatistics at 91ɫƵ. He has served as Statistical Director for various committees of the CIBMTR since joining 91ɫƵ in 2008, including the Lymphoma, Pediatric Cancer, Regimen-related Toxicity and Supportive Care, Chronic Leukemia, and Infection and Immune Reconstitution working committees. For the past two years he has served as the Associate Chief Statistical Director of the CIBMTR.
He has published over 150 peer reviewed manuscripts including 25 methodologic publications in leading statistical journals focusing on survival and competing risks data, variable selection and high-dimensional data analysis, most of which are directly applicable to the analysis of transplant and cell therapy data. He also successfully obtained multiple research grants as Principal Investigator, including a contract as PI with the FDA on “Commensurate Prior Models Accommodating Historical Controls for Clinical Trials with Matched and/or Interval-Censored Data”, as well as past grants with the National Science Foundation, the AHW endowment, and the 91ɫƵ Cancer Center. Dr. Ahn takes over this role from Dr. Mei-jie Zhang, who has served since 2015.
Please join us in congratulating Dr. Ahn on his promotion to this role, and thanking Dr. Zhang for his wonderful service to the CIBMTR as Chief Statistical Director these past nine years.